Literature DB >> 1399376

Diagnosis and treatment of cortical tumours of the suprarenal gland.

V Zvara1, J Breza, M Májek.   

Abstract

The authors report on their own groups of benign (20 patients) and malignant (14 patients) cortical tumours of the suprarenal gland. In both kinds of tumour the occurrence is higher in females. Adenoma occurred more often in the left adrenal gland and cancer in the right one. Some tumours manifested themselves by an increased production of suprarenal hormones, others were hormonally inactive and did not become manifest until the later stage of development. In the therapy of adenomas the classical lumbar approach through the 11th intercostal space is adequate, in the case of cancer and extended lumbotomy laparotomy or thoracotomy is necessary. The need of participation of other specialists in the treatment (endocrinologist, radiologist, oncologist, anaesthesiologist) is emphasized.

Entities:  

Mesh:

Year:  1992        PMID: 1399376     DOI: 10.1007/bf02549527

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  4 in total

Review 1.  Adrenocortical carcinoma.

Authors:  M F Brennan
Journal:  CA Cancer J Clin       Date:  1987 Nov-Dec       Impact factor: 508.702

2.  Primary aldosteronism due to adrenal carcinomas.

Authors:  T Lüscher; W Tenschert; A Salvetti; R Pedrinelli; R Maurer; F Turini; G Maltinti; H Vetter; W Vetter
Journal:  Klin Wochenschr       Date:  1984-05-15

3.  Steroidogenesis in an estrogen-producing adrenal tumor in a young woman: comparison with steroid profiles associated with cortisol- and androgen-producing tumors.

Authors:  T J McKenna; Y O'Connell; S Cunningham; M McCabe; M Culliton
Journal:  J Clin Endocrinol Metab       Date:  1990-01       Impact factor: 5.958

4.  Incidental asymptomatic adrenal masses detected by computed tomographic scanning. Is operation required?

Authors:  R A Prinz; M H Brooks; R Churchill; J L Graner; A M Lawrence; E Paloyan; M Sparagana
Journal:  JAMA       Date:  1982-08-13       Impact factor: 56.272

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.